Meeder Asset Management Inc Sarepta Therapeutics, Inc. Transaction History
Meeder Asset Management Inc
- $1.48 Billion
- Q3 2024
A detailed history of Meeder Asset Management Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 546 shares of SRPT stock, worth $65,230. This represents 0.0% of its overall portfolio holdings.
Number of Shares
546
Previous 525
4.0%
Holding current value
$65,230
Previous $82,000
17.07%
% of portfolio
0.0%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding SRPT
# of Institutions
529Shares Held
84.2MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.23 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.07 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$748 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$521 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$510 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.5B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...